Quest Diagnostics (DGX)

EBITDA Growth

14.08%

Quarterly · Period ending:

DGX logo

DGX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported14.08%
DGX Quarterly EBITDA YoY % (123.81% → 14.08%)
High-resolution chart · PNG

DGX ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Quest Diagnostics EBITDA Growth — Quarterly
Period endingEBITDA Growth
13.9798%
11.2227%
24.0346%
6.8312%
80.8507%
180.503%
154.5816%
124.6753%
78.2946%
7.9619%
-5.2609%
38.9892%
2.9255%
-5.5085%
7.8125%
105.9544%
123.8125%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.